This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: F. Hoffmann-La Roche Ag, Hoffmann-La Roche Inc.. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: Jayashree Sahni: Innovator in Vision Science
Introduction
Jayashree Sahni is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of vision science, particularly in the treatment of age-related macular degeneration and diabetic macular edema. With a total of 2 patents, her work is at the forefront of innovative medical solutions.
Latest Patents
One of her latest patents focuses on the "Treatment of Age-Related Macular Degeneration and Diabetic Macular Edema by Administration of a Bispecific Antibody to VEGF and ANG-2." This groundbreaking approach aims to improve treatment outcomes for patients suffering from these debilitating eye conditions. Another notable patent involves "Machine-learning techniques for prediction of future visual acuity." This patent describes methods and systems that utilize machine-learning models to predict a subject's future visual acuity by processing images of the retina and generating segment-specific metrics.
Career Highlights
Throughout her career, Jayashree has worked with leading companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical technology.
Collaborations
Jayashree has collaborated with notable professionals in her field, including Andreas Thalhammer and Yun Li. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
Jayashree Sahni's contributions to vision science through her patents and collaborations highlight her role as an influential inventor. Her innovative approaches to treating eye diseases and predicting visual acuity demonstrate her commitment to improving patient outcomes.

